Dexcom G7 15 Day is the longest‑lasting and most accurate 1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days 5. BURNABY, British ...

FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

Insulet Corporation (PODD) and DexCom (DXCM) were among notable gainers in MedTech on Tuesday after Deutsche Bank initiated the diabetes device makers with Buy ratings despite their sharp sell-off in ...

Following up on its landmark FDA clearance for pediatric use earlier this month, Dexcom is backing up its newly expanded hardware reach with an AI-driven app overhaul. Unveiled at the Aspen Ideas: ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with ...

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...

Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless devices. These monitors also connect to an app on your smartphone or Apple ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Los Angeles Chargers had one of the more interesting offseasons.

Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech integrations.